Editorial
 TOWARDS A PRESCRIPTION AUDIT   
 Tuesday, April 15, 2014 
 With continuous change in lifestyle of the people over the years, the disease profile of this country has changed dramatically leading to spread of several non infectious diseases among larger sections of Indian population. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Xeris Pharma's new stable non-aqueous glucagon formulations receives US patent
17:00  [IST]Patent protection losses will hinder HIV treatment market growth, says GBI Research
16:00  [IST]Teva settles generic Celebrex patent litigation with Pfizer
15:00  [IST]Neuralstem spinal cord injury stem cell trial approved to commence at University Of California
14:00  [IST]Almac gets New York State Laboratory Permit to receive patient samples for clinical testing
13:00  [IST]Antares Pharm's Otrexup receives additional US patent coverage
more news >>
TOP NEWS
08:00  [IST]ICMR issues consensus document for management of esophageal cancer
08:00  [IST]Tyco Security eyes Indian hospitals be tagged with RFID & RLTS Elpas location based tracking solutions
08:00  [IST]NITRD, BD set up centre of excellence for TB diagnostics
08:00  [IST]IHPA wants Govt of India to start refresher course for hospital pharmacists through NRHM.
08:00  [IST]‘Pharmalive’ new software application for pharmacies, distributors unveiled
08:00  [IST]Govt to procure Unani medicines from private sector for centrally-sponsored schemes
more news >>
YESTERDAY'S NEWS
18:00  [IST]Prosonix, Mylan enter global licensing pact for generic inhaled respiratory products Flixotide & Flovent
17:00  [IST]Certara acquires Delaware-based specialty CRO Synchrogenix
16:00  [IST]Mylan launches insomnia drug, eszopiclone tablets in US market
15:15  [IST]GlaxoSmithKline Pharma's net dips by 43% in Q1
15:00  [IST]EMA warns of falsified, tampered breast cancer drug Herceptin
13:30  [IST]Boehringer Ingelheim net declined by 4.3% to €14.1 billion in 2013
more news >>
INTERVIEW  
Knowledge empowerment of pharmacist would drive to achieve Pharma Vision 2020
DA Gundu Rao, president of KSPC
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is price control a deterrent to investment in Indian pharmaceutical sector as is being cited by a US govt report?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |